ArticleBrain communications2023

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4.

Marloes Stam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.